Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Clear earnings/guidance catalyst: Q2 2026 EPS of $1.26 beat $0.99 consensus, and management raised 2026 operating EPS guidance by 8% at the midpoint. Shares recovered steadily to the 21-day high, supported by favorable insurance-sector rotation.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Improvement ⢠High Leverage ⢠Rising Valuation CNO's stronger quarterly profitability and cash flow are tempered by high leverage, weak cash-to-debt coverage, and a more demanding valuation.
Price Behavior
Key Price Behavior Insights: ⢠Short-term uptrend ⢠Resistance test ⢠Healthy momentum Support Level: $55.30â$54.20 Resistance Level: $56.75 CNO gained 2.9% over the last month with healthy momentum, but needs a sustained break above $56.75 to confirm upside or risks pulling back toward $55.30â$54.20.
Sentiment & News
Key News Insights: ⢠Raised Guidance ⢠Worksite Expansion ⢠Institutional Buying CNO Financial's strong Worksite and Medicare growth, raised guidance, and rising institutional ownership signal improving momentum and investor confidence.
AI Summary
CNO is evolving into a higher-growth Worksite and Medicare distribution story, but at ~18x earnings and 2x book investors should buy only if accelerating sales converts into sustained underwriting margins and capital generation despite meaningful leverage and rate-sensitive book value.
Description
CNO Financial Group, through its subsidiaries, underwrites and administers a range of life, health and annuity products for middle-income and senior customers in the United States, including Medicare-related coverage, supplemental health and long-term care offerings. The company distributes its products via agents, independent producers, direct channels and worksite/group relationships, and markets under the Bankers Life, Washington National and Colonial Penn brands. Founded in 1979, CNO is headquartered in Carmel, Indiana.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jul 31 | Aug 7 | CNO | CNO Financial Group, Inc. | Clear earnings/guidance catalyst: Q2 2026 EPS of $1.26 beat $0.99 consensus, and management raised 2026 operating EPS guidance by 8% at the midpoint. Shares recovered steadily to the 21-day high, supported by favorable insurance-sector rotation. | Closed | +0.1% |